Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Meinl

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational researchReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.
The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targetsReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.
Trends in Immunology|August 4, 2018
Shedding of BAFF/APRIL Receptors Controls B CellsEdgar Meinl, Franziska S Thaler, Stefan F Lichtenthaler
Journal of Molecular Medicine (Berlin, Germany)|May 7, 2010
Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injuryTobias Derfuss, Chris Linington, Reinhard Hohlfeld, et al.
Nature Reviews. Neurology|October 10, 2012
B cells and antibodies in multiple sclerosis pathogenesis and therapyMarkus Krumbholz, Tobias Derfuss, Reinhard Hohlfeld, et al.
Multiple Sclerosis and Related Disorders|May 8, 2023
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosisVinícius Oliveira Boldrini, Simone Mader, Tania Kümpfel, et al.
Journal of the Neurological Sciences|August 22, 2008
Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosisEdgar Meinl, Markus Krumbholz, Tobias Derfuss, et al.
International Immunology|April 21, 2004
Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokinesCinthia Farina, Diethilde Theil, Barbara Semlinger, et al.
The Lancet. Neurology|August 20, 2005
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of actionCinthia Farina, Martin S Weber, Edgar Meinl, et al.
Journal of the Neurological Sciences|September 7, 2010
Humoral autoimmunity in multiple sclerosisEdgar Meinl, Tobias Derfuss, Markus Krumbholz, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational researchReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.
The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targetsReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.
Trends in Immunology|August 4, 2018
Shedding of BAFF/APRIL Receptors Controls B CellsEdgar Meinl, Franziska S Thaler, Stefan F Lichtenthaler
Journal of Molecular Medicine (Berlin, Germany)|May 7, 2010
Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injuryTobias Derfuss, Chris Linington, Reinhard Hohlfeld, et al.
Nature Reviews. Neurology|October 10, 2012
B cells and antibodies in multiple sclerosis pathogenesis and therapyMarkus Krumbholz, Tobias Derfuss, Reinhard Hohlfeld, et al.
Multiple Sclerosis and Related Disorders|May 8, 2023
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosisVinícius Oliveira Boldrini, Simone Mader, Tania Kümpfel, et al.
Journal of the Neurological Sciences|August 22, 2008
Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosisEdgar Meinl, Markus Krumbholz, Tobias Derfuss, et al.
International Immunology|April 21, 2004
Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokinesCinthia Farina, Diethilde Theil, Barbara Semlinger, et al.
The Lancet. Neurology|August 20, 2005
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of actionCinthia Farina, Martin S Weber, Edgar Meinl, et al.
Journal of the Neurological Sciences|September 7, 2010
Humoral autoimmunity in multiple sclerosisEdgar Meinl, Tobias Derfuss, Markus Krumbholz, et al.
Pageof 12